LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Breakthroughs Adaptimmune recently made a major breakthrough in cell therapies, indicating potential innovative products or services that could be attractive to clients seeking cutting-edge solutions.

Financial Partnerships Securing substantial financing, such as the $125 million debt financing deal with Hercules Capital, suggests financial stability and capability to scale operations, creating opportunities to offer more comprehensive solutions to clients.

Acquisitions Strategy Adaptimmune's acquisition of TCR2 Therapeutics Inc. showcases a growth-oriented strategy that could lead to expanded offerings, making it interesting for clients looking for diverse solutions from a single provider.

Top Talent Recruitment Hiring top talent like Dr. Karen Chagin as Senior Vice President of Early-Stage Development signals expertise and leadership, potentially attracting clients looking for partners with deep industry knowledge and experience.

Strategic Partnerships Through partnerships with companies like TCR2 Therapeutics Inc., Adaptimmune demonstrates collaboration and access to complementary technologies, offering clients access to a broader range of solutions and expertise.

Similar companies to Adaptimmune

Adaptimmune Tech Stack

Adaptimmune uses 8 technology products and services including SAS, Fortinet, Ubuntu, and more. Explore Adaptimmune's tech stack below.

  • SAS
    Business Intelligence
  • Fortinet
    Network Hardware
  • Ubuntu
    Operating Systems
  • Debian
    Operating Systems
  • Java
    Programming Languages
  • PHP
    Programming Languages
  • C++
    Programming Languages
  • HSTS
    Security

Media & News

Adaptimmune's Email Address Formats

Adaptimmune uses at least 1 format(s):
Adaptimmune Email FormatsExamplePercentage
First.Last@adaptimmune.comJohn.Doe@adaptimmune.com
85%
F.Last@adaptimmune.comJ.Doe@adaptimmune.com
12%
Last@adaptimmune.comDoe@adaptimmune.com
2%
First.Middle@adaptimmune.comJohn.Michael@adaptimmune.com
1%

Frequently Asked Questions

Where is Adaptimmune's headquarters located?

Minus sign iconPlus sign icon
Adaptimmune's main headquarters is located at 60 Jubilee Avenue Milton Park Abingdon, Oxfordshire OX14 4RX GB. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Adaptimmune's phone number?

Minus sign iconPlus sign icon
You can contact Adaptimmune's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adaptimmune's stock symbol?

Minus sign iconPlus sign icon
Adaptimmune is a publicly traded company; the company's stock symbol is ADAP.

What is Adaptimmune's official website and social media links?

Minus sign iconPlus sign icon
Adaptimmune's official website is adaptimmune.com and has social profiles on LinkedIn.

How much revenue does Adaptimmune generate?

Minus sign iconPlus sign icon
As of November 2024, Adaptimmune's annual revenue reached $75M.

What is Adaptimmune's SIC code NAICS code?

Minus sign iconPlus sign icon
Adaptimmune's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Adaptimmune have currently?

Minus sign iconPlus sign icon
As of November 2024, Adaptimmune has approximately 537 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: A. A. R.Chief Medical Officer: E. N.Chief Commercial Officer (cco): C. P.. Explore Adaptimmune's employee directory with LeadIQ.

What industry does Adaptimmune belong to?

Minus sign iconPlus sign icon
Adaptimmune operates in the Biotechnology Research industry.

What technology does Adaptimmune use?

Minus sign iconPlus sign icon
Adaptimmune's tech stack includes SASFortinetUbuntuDebianJavaPHPC++HSTS.

What is Adaptimmune's email format?

Minus sign iconPlus sign icon
Adaptimmune's email format typically follows the pattern of . Find more Adaptimmune email formats with LeadIQ.

How much funding has Adaptimmune raised to date?

Minus sign iconPlus sign icon
As of November 2024, Adaptimmune has raised $25M in funding. The last funding round occurred on May 15, 2024 for $25M.

When was Adaptimmune founded?

Minus sign iconPlus sign icon
Adaptimmune was founded in 2008.
Adaptimmune

Adaptimmune

Biotechnology ResearchOxfordshire, United Kingdom501-1000 Employees

Adaptimmune is a fully integrated cell therapy company, designed and built
from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com.  If interested in joining our fast growing team, click on the careers tab of this page.  

Section iconCompany Overview

Headquarters
60 Jubilee Avenue Milton Park Abingdon, Oxfordshire OX14 4RX GB
Phone number
SIC Code
2836 - Biological Products, Except Diagnostic Substances
Stock Symbol
ADAP
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
501-1000

Section iconFunding & Financials

  • $25M

    Adaptimmune has raised a total of $25M of funding over 9 rounds. Their latest funding round was raised on May 15, 2024 in the amount of $25M.

  • $50M$100M

    Adaptimmune's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $25M

    Adaptimmune has raised a total of $25M of funding over 9 rounds. Their latest funding round was raised on May 15, 2024 in the amount of $25M.

  • $50M$100M

    Adaptimmune's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.